Two Sigma Advisers’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,067
| Closed | -$31K | – | 2735 |
|
|
2021
Q1 | $31K | Sell |
1,067
-4,906
| -82% | -$143K | ﹤0.01% | 2513 |
|
|
2020
Q4 | $93K | Buy |
5,973
+60
| +1% | +$934 | ﹤0.01% | 2277 |
|
|
2020
Q3 | $57K | Sell |
5,913
-1,679
| -22% | -$16.2K | ﹤0.01% | 2316 |
|
|
2020
Q2 | $171K | Buy |
7,592
+98
| +1% | +$2.21K | ﹤0.01% | 2285 |
|
|
2020
Q1 | $137K | Buy |
7,494
+244
| +3% | +$4.46K | ﹤0.01% | 2257 |
|
|
2019
Q4 | $853K | Buy |
7,250
+121
| +2% | +$14.2K | ﹤0.01% | 1651 |
|
|
2019
Q3 | $647K | Buy |
+7,129
| New | +$647K | ﹤0.01% | 1613 |
|